-
-
Call more information
660-596-2224 -
Author: MARTIN MACIAS JR Courthouse News Service In the first analysis of its kind of prescription drug pricing in the United States, researchers found that the net cost of drugs – the price consumers paid, minus manufacturer discounts – grew three times faster than inflation over a decade. Researchers at the Center for Pharmaceutical Policy […]
Read MoreAuthor: Stefani Schwartz, MD The Frost Series # 356 Anesthesiology New Case Presentation A 28-year-old woman, with morbid obesity (body mass index, 54 kg/m2) with a Mallampati classification II airway presented for placement of a ventriculoperitoneal shunt to address idiopathic intracranial hypertension. After induction of general anesthesia with propofol (2 mg/kg) and succinylcholine (1 mg/kg), […]
Read MoreAUTHORS: Slupe, Andrew M. MD, PhD et al Anesthesia & Analgesia: December 2019 – Volume 129 – Issue 6 – p 1529-1535 BACKGROUND: Dexmedetomidine (Dex) is an attractive agent for procedural sedation due to its unique pharmacodynamic profile, specifically affording predictable sedation without concurrent respiratory depression. However, Dex has previously been reported to prevent or […]
Read MoreAUTHORS: Shin, Hyun-Jung MD, PhD et al Anesthesia & Analgesia: December 2019 – Volume 129 – Issue 6 – p 1512-1518 BACKGROUND: In patients undergoing total knee arthroplasty under spinal anesthesia, we compared the postoperative analgesic effect of intraoperative sedation with dexmedetomidine versus propofol. We hypothesized that sedation with dexmedetomidine would result in lower postoperative […]
Read MoreBy Kelly Young Gabapentin and pregabalin may cause serious breathing problems in patients who have respiratory risk factors, such as using opioids or other central nervous system depressants, having an underlying respiratory condition like chronic obstructive pulmonary disease, or being elderly, according to a safety update from the FDA. The agency notes that use and […]
Read More